Loading...
Cardiac Safety of Non-Anthracycline Trastuzumab-Based Therapy for HER2-Positive Breast Cancer
PURPOSE: Trastuzumab improves overall survival for women with HER2-positive breast cancer but is associated with cardiotoxicity, especially when administered after anthracyclines. Use of non-anthracycline trastuzumab-based regimens is rising, particularly for patients with low risk disease or with m...
Na minha lista:
| Udgivet i: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647229/ https://ncbi.nlm.nih.gov/pubmed/28710537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4362-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|